Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase 3 Open-Label Randomized Study to Compare the Efficacy And Safety of Rituximab Plus lenalidomide (CC-5013) versus Rituximab Plus Chemotherapy in Subjects with Previously Untreated Follicular Lymphoma
Fleischman, Roger
(PI)
Monohan, Gregory
(CoI)
Hayslip, John
(Former PI)
Shakil, Shams
(Former CoI)
Markey Cancer Center / Cancer Research Priority Initiative
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
4/12/12
→
8/21/23
Funding
Celgene:
$195,666.00
View all
View less